New Treatments for Rare Mutations in NSCLC
Category
  • Oncology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
Applying ADAURA in Practice: Implications for Early Stage EGFRm NSCLC - Medical Moment Two
Medical Moment Two: Expert Insight on Applying the ADAURA Results to Treatment of Early-Stage NSCLC Patients 
Category
  • Oncology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Applying ADAURA in Practice: Implications for Early Stage EGFRm NSCLC - Medical Moment One
Medical Moment One: Expert Insight on Practical Aspects of Molecular Profiling for Early-Stage NSCLC Cancers 
Category
  • Oncology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
How Do We Identify HER2+ Gastric Cancer?
The implementation of molecular testing, especially analysis of human epidermal growth factor receptor 2 (HER2) status, has had a significant impact on clinical practice and patient care. Join Drs.
Category
  • Oncology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
How Do Antibody-Drug Conjugates (ADCs) Fit into Precision Medicine for Gastric Cancer?
Antibody-drug conjugates or “ADCs” are a novel class of highly potent biopharmaceutical drug composed of an antibody linked, via a chemical linker, to a biologically active drug or cytotoxic compound. Nearly 150 investigational ADCs are currently in pre-clinical and clinical trials. Join Drs.
Category
  • Oncology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
What’s the Best Approach to Select Targeted Treatments for HER2+ Gastric Cancer and What are Practical Considerations?
Clinicians must be aware and up-to-date on the most effective approaches to management in order to provide patients with the most appropriate course of therapy. Join Drs.
Category
  • Oncology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Medical Moment Three: Multidisciplinary Collaboration  in the Management of Patients with Heart Failure
Heart failure is a major public-health problem resulting in substantial morbidity and mortality for the US. Unfortunately, challenges and barriers to effective use of guideline-directed medical therapies (GDMT) among hospitalized patients with HFrEF remain. Join Drs.
Category
  • Cardiology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Medical Moment One: Novel Pharmacologic Approaches in a Symptomatic, High-risk HFrEF Patient Population
Join Drs. Muthiah Vaduganathan and Javed Butler for this on-demand online activity, as they examine novel methodologies to address the clinical worsening of HFrEF, with a focus on recently-reported results from the VICTORIA trial.
Category
  • Cardiology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Medical Moment Two: Multifaceted Challenges in Medical Therapy Optimization during Episodes of Worsening HFrEF
Initiating and optimizing in-hospital guideline-directed medical therapies (GDMT) remains a challenge for clinicians treating patients with worsening HFrEF. Join Drs.
Category
  • Cardiology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation